Ranbaxy Labs Dec qtr PAT seen up 2.4% at Rs 261.8cr: Karvy

Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Ranbaxy Laboratories December quarter sales are expected to go down by 2.5% at Rs 2197.7 crore, Year-on-Year, (YoY) basis.

January 11, 2011 / 16:47 IST

Story continues below Advertisement

Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Ranbaxy Laboratories December quarter sales are expected to go down by 2.5% at Rs 2197.7 crore, Year-on-Year, (YoY) basis.

The company's net profit is expected to go up by 2.4% at Rs 261.8 crore on YoY basis.

first published: Jan 11, 2011 04:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Ranbaxy Labs Dec qtr PAT seen up 2.4% at Rs 261.8cr: Karvy

Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Ranbaxy Laboratories December quarter sales are expected to go down by 2.5% at Rs 2197.7 crore, Year-on-Year, (YoY) basis.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links